Overview

The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study

Status:
RECRUITING
Trial end date:
2025-07-30
Target enrollment:
Participant gender:
Summary
The main aim of the present study is to investigate the effects of orally administered vasopressin (AVP) on bottom-up and top-down attentional control to socio-emotional stimuli by combining a validated saccade/antisaccade eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design.
Phase:
NA
Details
Lead Sponsor:
University of Electronic Science and Technology of China
Treatments:
Vasopressins